Ex vivo studies of NHL patient samples revealed that direct cell contact with tumor cells induced differentiation of autologous PBMCs into CD4+CD25+FoxP3+ Tregs that were found to be directly responsible for effector T cell hyporesponsiveness by in vitro depletion experiments [73,78]. The gene discussed is FOXP3; the disease is non-Hodgkin lymphoma.